InvestorsHub Logo
Followers 33
Posts 12837
Boards Moderated 0
Alias Born 08/29/2012

Re: None

Thursday, 01/28/2021 4:16:59 AM

Thursday, January 28, 2021 4:16:59 AM

Post# of 403204
***** MUST READ!!!!! - MAJOR updates to Elite's website. *****

Some of you have already posted a few of the updates Elite has made on their website.

I'm going to list all the ones I found here.

----------------------------------------------------------------------------------------------------------------------------------------

1. New "OVERVIEW" description.

https://www.elitepharma.com/about-elite/

OVERVIEW

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology for the manufacture of generic pharmaceuticals.

Our strategy includes developing generic versions of controlled-release drug products with high-barriers to entry.

Elite owns multiple generic products which have been licensed to Lannett Company, Glenmark Pharmaceuticals, Inc., and TAGI Pharma.

Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ.

----------------------------------------------------------------------------------------------------------------------------------------

2. Updated "GENERIC PRODUCTS" page.

https://www.elitepharma.com/products/

A. Loxapine Capsules are no longer listed as "pending manufacturer site transfer" because they are launching THIS quarter.

B. "Additional Approved ANDA's" product line item has been removed.

----------------------------------------------------------------------------------------------------------------------------------------

3. "CO-DEVELOPMENT PIPELINE WITH SUNGEN PHARMA LLC" has been completely removed.

----------------------------------------------------------------------------------------------------------------------------------------

4. "GENERIC PIPELINE" has been updated with the following paragraph:

https://www.elitepharma.com/pipeline-generics/

- "Elite is developing differentiated niche generic products for future growth. Elite’s focus is on solid oral dose products that are hard to formulate, such as extended-release products and products that we believe have competitive advantages. Elite also continues to evaluate contract development, contract manufacturing, and in-licensing opportunities. Updates on development projects will be provided upon achieving key milestones."

----------------------------------------------------------------------------------------------------------------------------------------

5. "BRANDED PIPELINE" has been updated. The ONLY branded ART opioid that remains in the pipeline is SequesOx.

https://www.elitepharma.com/pipeline-branded/

GREEN = Remained
RED = Removed

SequestOx (ELI-200) Opioid Pain NDA Submitted Pending Approval
ELI-216 Opioid Pain Process Development
ELI-500 Opioid Pain Process Development
ELI-501 Opioid Pain Early Development
ELI-600 Opioid Pain Process Development
ELI-601 Opioid Pain Early Development


----------------------------------------------------------------------------------------------------------------------------------------





"Most people get interested in stocks when everyone else is. The time to get interested is when no one else is. You can't buy what is popular and do well." - Warren Buffett

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News